HOME > About SEKISUI > What's New Archive > 2010 > German Subsidiary operating Poly-Olefin foam business changes the company name

What's New Archive

Press Release
German Subsidiary operating Poly-Olefin foam business changes the company name
Jun 8, 2010

From "Polymer-Tec G.m.b.H." to "Sekisui Alveo BS G.m.b.H."


Sekisui Chemical Co.,Ltd (President, Mr. Naofumi Negishi, hereafter called in "Sekisui Chemical"), High Performance Plastics Company (Company president, Mr. Takayoshi Matsunaga), is operating foam business on a global basis mainly by Cross-linked Poly-Olefin foam which is used as a material for heat insulation, cushioning sealing and so on.
Please be informed that the company name of German subsidiary "Polymer-Tec G.m.b.H.", operating Non Cross-linked Poly-Olefin foam business will be changed to "Sekisui Alveo BS G.m.b.H." as of 1st of July, 2010.

< The outline of company >
1)Company name : Sekisui Alveo BS G.m.b.H. (from the 1st of July)
2)The contents of Business : manufacturing and Sales of Non Cross-linked Poly-Olefin foam
3)Location : Haystrasse 14-20 D-55566 Bad Sobernheim, Germany
4)Managing Director : Dirk Kropp
5)Established in 1980.
6) Capital : 64.000 Euro (about 7 million yen)
*100% owned by Sekisui Alveo A.G. which is 100% subsidiary of Sekisui Chemical
7)Completion of M&A ; 31st of December, 2009 in European time.
8)Employees : about 70 people
9)Sales turnover : about 16.3 million euro (about 18 billion yen)
*112 yen/euro as exchange rate

< References >

1) Cross-linking
Binding molecular each other makes the material increase in strength.
2) Cross-linked Poly-Olefin foam
Foamed Product after making Poly-Olefin resin Cross-linking by irradiator or chemical reaction. Cross-linking adds the following functions such as heat resistance, high tear strength, weathering resistance and so on.
3) Non Cross-linked Poly-Olefin foam
High productivity compared with Cross-linked Poly-Olefin foam. Main application is for packaging, cushioning and so on.

Press Contact

Corporate Communication Department
Fax: (+81) 3-5521-0510


This press release may contain forward-looking statements. Such forward-looking statements are based on current expectations and beliefs and are subject to a number of factors and uncertainties that could cause actual results to differ materially from those expressed or implied by such statements due to changes in global economic, business, competitive market and regulatory factors.
Page Top